Glaxo-Smith-Kline says its anti-depressant Paxil "may" be linked more often to birth defects than similar drugs.
In a new study, women exposed to Paxil or other antidepressants during the first trimester suggested an increased risk of major congenital malformations among women taking Paxil.
GSK is adding the information to Paxil's label and sending letters to doctors.
GSK adds that an even larger study by the Swedish medical birth registry found no increased risk for overall malformations among women taking Paxil.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.